Theravance Inc $35.63
|Trade Time:||Dec 11 01:29 PM Eastern Daylight Time|
|Change:||-1.14 (-3.10 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get THRX Trend Analysis - it has outperformed the S&P 500 by 40%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|11/20/2013||Mammen Mathai||SVP, Research & Early Clin Dev||-4,569||$36.40||-2.02%|
|11/20/2013||Shafer Bradford J||Sr VP, Gen. Counsel, Secretary||-4,569||$36.40||-1.50%|
|11/20/2013||Winningham Rick E||Chief Executive Officer||-10,046||$36.40||-1.46%|
|11/20/2013||Aguiar Michael W||Sr VP, Chief Financial Officer||-4,569||$36.40||-3.30%|
|9/12/2013||Winningham Rick E||Chief Executive Officer||-22,353||$40.03||-3.14%|
THRX Stock Analysis
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!